MPLT insider transaction filings
MapLight Therapeutics, Inc. — 50 most recent Form 4 filings from SEC EDGAR, normalized by FilingPulse. Latest filing: 2026-08-19. Screen MPLT transaction legs live →
| Filed | Form | Insider | Reported transactions | Source |
|---|---|---|---|---|
| 2026-08-19 | 4 | Foff Erin Pennock — Chief Medical Officer | Grant/award (A): 13,360 @ $0 · Grant/award (A): 54,240 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Hanson Kristopher — General Counsel | Grant/award (A): 7,730 @ $0 · Grant/award (A): 31,395 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Lillie James Woodruff — Chief Scientific Officer | Grant/award (A): 7,730 @ $0 · Grant/award (A): 31,395 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | GILLIS JONATHAN — CAO and Interim CFO | Grant/award (A): 6,020 @ $0 · Grant/award (A): 2,222 @ $0 · Grant/award (A): 24,455 (derivative) @ $0 · Grant/award (A): 2,813 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Kreitzer Anatol — Chief Discovery Officer | Grant/award (A): 6,020 @ $0 · Grant/award (A): 24,455 (derivative) @ $0 | EDGAR |
| 2026-08-19 | 4 | Kroeger Christopher A. — Chief Executive Officer, Director | Grant/award (A): 23,145 @ $0 · Grant/award (A): 93,955 (derivative) @ $0 | EDGAR |
| 2026-08-04 | 4 | Lillie James Woodruff — Chief Scientific Officer | Sale (S): 22,082 @ $12.54 | EDGAR |
| 2026-07-28 | 4 | Cox Troy — Director | Purchase (P): 15,620 @ $9.52 | EDGAR |
| 2026-07-20 | 4 | Kreitzer Anatol — Chief Discovery Officer | Sale (S): 5,545 @ $36.13 · Sale (S): 4,510 @ $36.94 · Sale (S): 7,464 @ $36.66 · Sale (S): 1,592 @ $37.44 · Sale (S): 2,833 @ $37.05 · Sale (S): 14,140 @ $37.70 · +1 more | EDGAR |
| 2026-07-20 | 4 | GILLIS JONATHAN — CAO and Interim CFO | Sale (S): 5,356 @ $36.13 · Sale (S): 4,699 @ $36.94 · Sale (S): 6,979 @ $36.66 · Sale (S): 1,476 @ $37.44 · Sale (S): 600 @ $36.51 · Sale (S): 16,969 @ $37.61 · +1 more | EDGAR |
| 2026-07-17 | 4 | Foff Erin Pennock — Chief Medical Officer | Sale (S): 7,155 @ $36.16 · Sale (S): 7,845 @ $37.04 · Sale (S): 4,465 @ $36 · Sale (S): 8,972 @ $36.99 · Sale (S): 18 @ $37.54 · Sale (S): 9,163 @ $36.46 · +3 more | EDGAR |
| 2026-07-17 | 4 | Hanson Kristopher — General Counsel | Sale (S): 2,147 @ $36 · Sale (S): 5,103 @ $36.99 · Sale (S): 10 @ $37.54 · Sale (S): 4,776 @ $36.45 · Sale (S): 3,331 @ $37.26 · Sale (S): 11 @ $37.96 · +1 more | EDGAR |
| 2026-07-17 | 4 | Lillie James Woodruff — Chief Scientific Officer | Sale (S): 2,238 @ $36 · Sale (S): 5,393 @ $36.99 · Sale (S): 12 @ $37.54 · Sale (S): 5,009 @ $36.45 · Sale (S): 3,526 @ $37.26 · Sale (S): 12 @ $37.96 · +1 more | EDGAR |
| 2026-07-17 | 4 | Kroeger Christopher A. — Chief Executive Officer, Director | Sale (S): 18,950 @ $36 · Sale (S): 42,738 @ $36.99 · Sale (S): 90 @ $37.54 · Sale (S): 40,899 @ $36.46 · Sale (S): 28,091 @ $37.26 · Sale (S): 92 @ $37.96 · +1 more | EDGAR |
| 2026-06-25 | 4 | Luneborg Nanna Liebach — Director | Grant/award (A): 3,932 @ $0 · Grant/award (A): 14,902 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Garnett Timothy John — Director | Grant/award (A): 3,932 @ $0 · Grant/award (A): 14,902 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Walker Maria C — Director | Grant/award (A): 3,932 @ $0 · Grant/award (A): 14,902 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Cox Troy — Director | Grant/award (A): 7,864 @ $0 · Grant/award (A): 29,804 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Pavlov George — Director | Grant/award (A): 3,932 @ $0 · Grant/award (A): 14,902 (derivative) @ $0 | EDGAR |
| 2026-06-25 | 4 | Babler Martin — Director | Grant/award (A): 7,864 @ $0 · Grant/award (A): 29,804 (derivative) @ $0 | EDGAR |
| 2026-05-18 | 4 | Kroeger Christopher A. — Chief Executive Officer, Director | Sale (S): 118,037 @ $27.19 · Sale (S): 198 @ $28.15 | EDGAR |
| 2026-05-11 | 4 | Foff Erin Pennock — Chief Medical Officer | Sale (S): 4,321 @ $28.52 · Sale (S): 117 @ $29.10 | EDGAR |
| 2026-05-11 | 4 | Hanson Kristopher — General Counsel | Sale (S): 284 @ $27.61 · Sale (S): 846 @ $28.70 · Sale (S): 6,979 @ $30.04 · Sale (S): 5,808 @ $30.56 | EDGAR |
| 2026-05-11 | 4 | Lillie James Woodruff — Chief Scientific Officer | Sale (S): 721 @ $28.28 | EDGAR |
| 2026-05-11 | 4 | Kroeger Christopher A. — Chief Executive Officer, Director | Sale (S): 14,880 @ $28.47 · Sale (S): 5,220 @ $29.15 · Sale (S): 29,624 @ $27.48 · Sale (S): 1,582 @ $28.56 · Sale (S): 3,205 @ $29.20 · Sale (S): 342 @ $27.57 · +3 more | EDGAR |
| 2026-05-06 | 4 | Setia Vishwas — Chief Financial Officer | Sale (S): 4,803 @ $27.36 · Sale (S): 8,989 @ $28.28 · Sale (S): 325 @ $29.56 · Sale (S): 787 @ $30.12 · Sale (S): 9,935 @ $28.12 · Sale (S): 968 @ $29 · +2 more | EDGAR |
| 2026-05-06 | 4 | Foff Erin Pennock — Chief Medical Officer | Sale (S): 9,180 @ $27.50 · Sale (S): 5,460 @ $28.37 · Sale (S): 312 @ $29.56 · Sale (S): 700 @ $30.08 · Sale (S): 9,645 @ $28.12 · Sale (S): 931 @ $29 · +2 more | EDGAR |
| 2026-05-06 | 4 | Hanson Kristopher — General Counsel | Sale (S): 9,030 @ $27.50 · Sale (S): 3,908 @ $28.29 · Sale (S): 296 @ $29.56 · Sale (S): 683 @ $30.08 | EDGAR |
| 2026-05-06 | 4 | Lillie James Woodruff — Chief Scientific Officer | Sale (S): 9,250 @ $27.50 · Sale (S): 5,526 @ $28.37 · Sale (S): 320 @ $29.56 · Sale (S): 705 @ $30.08 · Sale (S): 10,132 @ $28.12 · Sale (S): 963 @ $29 · +2 more | EDGAR |
| 2026-05-06 | 4 | Kroeger Christopher A. — Chief Executive Officer, Director | Sale (S): 9,136 @ $27.50 · Sale (S): 5,427 @ $28.37 · Sale (S): 311 @ $29.56 · Sale (S): 697 @ $30.08 · Sale (S): 9,544 @ $28.12 · Sale (S): 928 @ $29 · +2 more | EDGAR |
| 2026-04-29 | 4 | Kreitzer Anatol — Chief Discovery Officer | Sale (S): 8,346 @ $28.96 · Sale (S): 29,255 @ $29.63 · Sale (S): 7,821 @ $30.50 | EDGAR |
| 2026-04-29 | 4 | GILLIS JONATHAN — CAAO and PAO | Sale (S): 7,914 @ $28.94 · Sale (S): 29,623 @ $29.60 · Sale (S): 14,363 @ $30.46 · Sale (S): 17,235 @ $30.33 · Sale (S): 700 @ $30.83 | EDGAR |
| 2026-04-17 | 4 | Setia Vishwas — Chief Financial Officer | Sale (S): 2,806 @ $26.87 · Sale (S): 29 @ $27.01 · Sale (S): 87 @ $27.49 | EDGAR |
| 2026-04-17 | 4 | Kreitzer Anatol — Chief Discovery Officer | Sale (S): 3,316 @ $26.61 | EDGAR |
| 2026-04-17 | 4 | Foff Erin Pennock — Chief Medical Officer | Sale (S): 2,044 @ $26.84 · Sale (S): 288 @ $27.01 · Sale (S): 881 @ $27.49 | EDGAR |
| 2026-04-17 | 4 | Malenka Robert C. — Director | Sale (S): 8,593 @ $26.90 | EDGAR |
| 2026-04-17 | 4 | Hanson Kristopher — General Counsel | Sale (S): 1,529 @ $26.80 · Sale (S): 73 @ $27.01 · Sale (S): 225 @ $27.49 | EDGAR |
| 2026-04-17 | 4 | Lillie James Woodruff — Chief Scientific Officer | Sale (S): 1,730 @ $26.82 · Sale (S): 686 @ $27.01 · Sale (S): 2,097 @ $27.49 | EDGAR |
| 2026-04-17 | 4 | GILLIS JONATHAN — CAAO and PAO | Sale (S): 3,590 @ $26.61 | EDGAR |
| 2026-04-17 | 4 | Kroeger Christopher A. — Chief Executive Officer, Director | Sale (S): 9,135 @ $26.93 · Sale (S): 2,477 @ $27.01 · Sale (S): 7,575 @ $27.49 | EDGAR |
| 2026-02-24 | 4 | Malenka Robert C. — Director | Sale (S): 2,195 @ $18.03 · Sale (S): 10,788 @ $18.39 · Sale (S): 476 @ $19.06 · Sale (S): 736 @ $18.15 | EDGAR |
| 2026-02-20 | 4 | Pavlov George — Director | Purchase (P): 10,658 @ $17.48 · Purchase (P): 4,422 @ $17.57 · Purchase (P): 9,920 @ $17.86 | EDGAR |
| 2026-02-18 | 4 | Malenka Robert C. — Director | Sale (S): 12,116 @ $18.21 | EDGAR |
| 2026-02-12 | 4 | Malenka Robert C. — Director | Sale (S): 6,622 @ $18.12 · Sale (S): 241 @ $18 | EDGAR |
| 2026-02-12 | 4 | Garnett Timothy John — Director | Purchase (P): 14,124 @ $17.89 | EDGAR |
| 2026-02-09 | 4 | Setia Vishwas — Chief Financial Officer | Grant/award (A): 7,730 @ $0 · Grant/award (A): 31,395 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Kreitzer Anatol — Chief Discovery Officer | Grant/award (A): 6,020 @ $0 · Grant/award (A): 24,455 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Foff Erin Pennock — Chief Medical Officer | Grant/award (A): 13,360 @ $0 · Grant/award (A): 54,240 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Hanson Kristopher — General Counsel | Grant/award (A): 7,730 @ $0 · Grant/award (A): 31,395 (derivative) @ $0 | EDGAR |
| 2026-02-09 | 4 | Lillie James Woodruff — Chief Scientific Officer | Grant/award (A): 7,730 @ $0 · Grant/award (A): 31,395 (derivative) @ $0 | EDGAR |
Recent 8-K events — MapLight Therapeutics, Inc.
| Filed | Form | Items reported | Source |
|---|---|---|---|
| 2026-08-13 | 8-K | 1.01 — Entry into a Material Definitive Agreement 2.02 — Results of Operations and Financial Condition 3.02 — Unregistered Sales of Equity Securities 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-07-27 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-24 | 8-K | 5.07 — Submission of Matters to a Vote of Security Holders | EDGAR |
| 2026-06-22 | 8-K | 7.01 — Regulation FD Disclosure 8.01 — Other Events 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-06-18 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-05-14 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-04-29 | 8-K | 5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | EDGAR |
| 2026-03-26 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2026-01-09 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
| 2025-12-04 | 8-K | 2.02 — Results of Operations and Financial Condition 7.01 — Regulation FD Disclosure 9.01 — Financial Statements and Exhibits | EDGAR |
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?ticker=MPLT returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. API docs →